Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients (Q57912015)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1999

Language	Label	Description	Also known as
English	Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients	scientific article published on 01 December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

multiple sclerosis

0 references

Claudio Gasperini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Massimo Filippi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M Rovaris

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Capra

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

V Martinelli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Prandini

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Pozzilli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Comi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Journal of the Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

171

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

130-134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Does interferon beta cause initial exacerbation of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900265-8

7 January 2021

Identifiers

10.1016/S0022-510X(99)00265-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581379%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57912015&oldid=2227873815"